cancer vaccine

Showing 12 posts of 12 posts found.


Boehringer pays $600m for cancer vaccine deal

September 19, 2014
Research and Development, Sales and Marketing Boehringer Ingelheim, cancer vaccine, oncology, pd1

Boehringer is hoping to expand its oncology pipeline with a new multi-million dollar pact for an investigational cancer vaccine. The …

Pfizer to develop phase II cancer vaccine

September 4, 2012
Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine

Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …

Yervoy (ipilimumab)

BMS launches skin cancer treatment Yervoy in UK

August 22, 2011
Sales and Marketing Yervoy, cancer vaccine, ipilimumab, skin cancer

Bristol-Myers Squibb’s skin cancer treatment Yervoy has been launched in the UK for patients with the deadliest form of the …

BMS skin cancer vaccine hits phase III target

March 23, 2011
Research and Development BMS, Bristol-Myers Squibb, advanced inoperable skin cancer, advanced melanoma, cancer drugs, cancer vaccine, ipilimumab

Bristol Myers Squibb’s cancer vaccine ipilimumab has increased overall survival in advanced melanoma patients. The therapy was being tested as …

Amgen HQ

Amgen signs $1 billion cancer biotech deal

January 25, 2011
Research and Development Amgen, BioVex, OncoVEXGM-CSF, cancer vaccine

Amgen is set to pay $1 billion for US biotech firm BioVex, in the process gaining access to its novel …

Dendreon will outsource first Provenge production in EU

January 11, 2011
Manufacturing and Production Dendreon, Provenge, cancer vaccine, contract manufacturing, sipuleucel-T, vaccine manufacturing, vaccines

US oncology specialist Dendreon has decided to hire a contract manufacturer for its cell-based cancer therapy Provenge in Europe to …

Dendreon eyes late 2011 European cancer vaccine filing

January 10, 2011
Sales and Marketing Cancer, Denreon, Provenge, cancer vaccine, sipuleucel, vaccines

Dendreon Group is to seek marketing authorisation in Europe for the world’s first immunotherapy cancer vaccine in late 2011 or …

Bavarian Nordic courting cancer vaccine backers

November 12, 2010
Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan

Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …

Transgene acquires rights to cancer vaccine

September 10, 2010
Research and Development JX-594, Jennerex, Transgene, cancer vaccine

French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …

Pfizer drops brain cancer vaccine

September 7, 2010
Research and Development Celldex Therapeutics, Pfizer, cancer vaccine

Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …

Lung cancer vaccine poised to begin phase IIb/III trials

September 1, 2010
Research and Development NSCLC, TG4010, Transgene, cancer vaccine

French biotech firm Transgene has received positive scientific advice from the EMA for late stage trials of its new lung …

Trials of cancer vaccine Stimuvax can resume

June 17, 2010
Research and Development Merck Serono, Stimuvax, cancer vaccine, vaccines

Merck Serono has been given clearance to resume part of its clinical trials of its cancer vaccine Stimuvax. Trials of …

Latest content